Reports of dolutegravir exposure and neural tube defects to the WHO VigiBase

ENTIS affiliated researchers from the Centre Regional de Pharmacovigilance, Assistance Publique-Hopitaux de Paris (Paris-COCHIN) have analysed the spontaneous reports of gestational dolutegravir exposure and neural tube defects in the WHO worldwide pharmacovigilance database (VigiBase). More information here.

Photo by freestocks.org on Unsplash